{"id":1709,"date":"2024-02-29T09:35:31","date_gmt":"2024-02-29T08:35:31","guid":{"rendered":"https:\/\/www.access2meds.eu\/?p=1709"},"modified":"2024-06-05T12:59:51","modified_gmt":"2024-06-05T10:59:51","slug":"ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia","status":"publish","type":"post","link":"https:\/\/www.access2meds.eu\/hr\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/","title":{"rendered":"ASCERTAIN at the 6th EUROPEAN CAR T-CELL MEETING in Valencia"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\" id=\"h-a-catalyst-for-collaborative-advances-in-cancer-immunotherapy\">A catalyst for collaborative advances in cancer immunotherapy<\/h2>\n\n\n\n<p>On 16th of February, Dr Frederick Thielen represented ASCERTAIN at the 6th European CAR T-cell Meeting. His journey began by attending the meeting of the T2EVOLVE consortium, an EU-funded initiative pioneering collaboration between leading scientists and industry in cancer immunotherapy. This ground-breaking alliance aims to accelerate the development, raise awareness, and improve access to immunotherapies, in particular using genetically engineered T cell receptors (TCRs) or synthetic chimeric antigen receptors (CARs). ASCERTAIN&#8217;s collaboration with T2EVOLVE underscores our commitment to improving access to novel therapies such as CAR T-cell therapy.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/02\/CAR-T-Cell-0224-1024x576.jpeg\" alt=\"\" class=\"wp-image-1710\" srcset=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/02\/CAR-T-Cell-0224-980x551.jpeg 980w, https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/02\/CAR-T-Cell-0224-480x270.jpeg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n\n\n\n<p><br>During the CAR T-cell meeting, Frederick presented ASCERTAIN in a session dedicated to European projects and networks, emphasising the central role of collaboration in advancing CAR T-cell therapy. His presentation generated lively interest in ASCERTAIN, sparking dynamic discussions and fostering connections with researchers from various European projects that paved the way for potential collaborations. The ASCERTAIN team looks forward to further exploring these collaborative opportunities to drive innovation in cancer treatment.<\/p>\n\n\n\n<p>You can gain further insights into the project in the interview with Frederick:<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"574\" src=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/02\/VHJ-Interview-1024x574.jpg\" alt=\"\" class=\"wp-image-1711\" srcset=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/02\/VHJ-Interview-1024x574.jpg 1024w, https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/02\/VHJ-Interview-980x549.jpg 980w, https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/02\/VHJ-Interview-480x269.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n\n\n\n<p><a href=\"https:\/\/www.vjhemonc.com\/video\/4ksb0unq_qe-ascertain-consortium-aiming-to-improve-affordability-and-accessibility-to-novel-health-technologies\/\">Click here to watch the video.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>On 16th of February, Dr Frederick Thielen represented ASCERTAIN at the 6th European CAR T-cell Meeting. His journey began by attending the meeting of the T2EVOLVE consortium, an EU-funded initiative pioneering collaboration between leading scientists and industry in cancer immunotherapy. <\/p>\n","protected":false},"author":5,"featured_media":1450,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1],"tags":[21,14,22,20],"class_list":["post-1709","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allgemein","tag-health-technologies","tag-healthcare","tag-hta","tag-innovative-health-technologies"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.8 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ASCERTAIN at the 6th EUROPEAN CAR T-CELL MEETING in Valencia - ASCERTAIN<\/title>\n<meta name=\"description\" content=\"On 16th of February, Dr Frederick Thielen represented ASCERTAIN at the 6th European CAR T-cell Meeting.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/\" \/>\n<meta property=\"og:locale\" content=\"hr_HR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASCERTAIN at the 6th EUROPEAN CAR T-CELL MEETING in Valencia\" \/>\n<meta property=\"og:description\" content=\"On 16th of February, Dr Frederick Thielen represented ASCERTAIN at the 6th European CAR T-cell Meeting.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/\" \/>\n<meta property=\"og:site_name\" content=\"ASCERTAIN\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-29T08:35:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-05T10:59:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2005\" \/>\n\t<meta property=\"og:image:height\" content=\"1254\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lena Jessen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:site\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:label1\" content=\"Napisao\/la\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lena Jessen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Procijenjeno vrijeme \u010ditanja\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\\\/\"},\"author\":{\"name\":\"Lena Jessen\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/person\\\/84cb4791d2eba62e68ecb7f29dba9391\"},\"headline\":\"ASCERTAIN at the 6th EUROPEAN CAR T-CELL MEETING in Valencia\",\"datePublished\":\"2024-02-29T08:35:31+00:00\",\"dateModified\":\"2024-06-05T10:59:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\\\/\"},\"wordCount\":199,\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"keywords\":[\"health technologies\",\"healthcare\",\"HTA\",\"innovative health technologies\"],\"articleSection\":[\"Allgemein\"],\"inLanguage\":\"hr\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\\\/\",\"name\":\"ASCERTAIN at the 6th EUROPEAN CAR T-CELL MEETING in Valencia - ASCERTAIN\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"datePublished\":\"2024-02-29T08:35:31+00:00\",\"dateModified\":\"2024-06-05T10:59:51+00:00\",\"description\":\"On 16th of February, Dr Frederick Thielen represented ASCERTAIN at the 6th European CAR T-cell Meeting.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\\\/#breadcrumb\"},\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"width\":2005,\"height\":1254},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.access2meds.eu\\\/hr\\\/pocetna-stranica\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ASCERTAIN at the 6th EUROPEAN CAR T-CELL MEETING in Valencia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"name\":\"ASCERTAIN\",\"description\":\"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.access2meds.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hr\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\",\"name\":\"ASCERTAIN\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ASCERTAIN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/ASCERTAIN_EU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ascertain-eu\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@ascertainproject\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/person\\\/84cb4791d2eba62e68ecb7f29dba9391\",\"name\":\"Lena Jessen\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ASCERTAIN at the 6th EUROPEAN CAR T-CELL MEETING in Valencia - ASCERTAIN","description":"On 16th of February, Dr Frederick Thielen represented ASCERTAIN at the 6th European CAR T-cell Meeting.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/","og_locale":"hr_HR","og_type":"article","og_title":"ASCERTAIN at the 6th EUROPEAN CAR T-CELL MEETING in Valencia","og_description":"On 16th of February, Dr Frederick Thielen represented ASCERTAIN at the 6th European CAR T-cell Meeting.","og_url":"https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/","og_site_name":"ASCERTAIN","article_published_time":"2024-02-29T08:35:31+00:00","article_modified_time":"2024-06-05T10:59:51+00:00","og_image":[{"width":2005,"height":1254,"url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","type":"image\/jpeg"}],"author":"Lena Jessen","twitter_card":"summary_large_image","twitter_creator":"@ASCERTAIN_EU","twitter_site":"@ASCERTAIN_EU","twitter_misc":{"Napisao\/la":"Lena Jessen","Procijenjeno vrijeme \u010ditanja":"2 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/#article","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/"},"author":{"name":"Lena Jessen","@id":"https:\/\/www.access2meds.eu\/#\/schema\/person\/84cb4791d2eba62e68ecb7f29dba9391"},"headline":"ASCERTAIN at the 6th EUROPEAN CAR T-CELL MEETING in Valencia","datePublished":"2024-02-29T08:35:31+00:00","dateModified":"2024-06-05T10:59:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/"},"wordCount":199,"publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"image":{"@id":"https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","keywords":["health technologies","healthcare","HTA","innovative health technologies"],"articleSection":["Allgemein"],"inLanguage":"hr"},{"@type":"WebPage","@id":"https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/","url":"https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/","name":"ASCERTAIN at the 6th EUROPEAN CAR T-CELL MEETING in Valencia - ASCERTAIN","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/#primaryimage"},"image":{"@id":"https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","datePublished":"2024-02-29T08:35:31+00:00","dateModified":"2024-06-05T10:59:51+00:00","description":"On 16th of February, Dr Frederick Thielen represented ASCERTAIN at the 6th European CAR T-cell Meeting.","breadcrumb":{"@id":"https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/#breadcrumb"},"inLanguage":"hr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/"]}]},{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/#primaryimage","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","width":2005,"height":1254},{"@type":"BreadcrumbList","@id":"https:\/\/www.access2meds.eu\/ascertain-at-the-6th-european-car-t-cell-meeting-in-valencia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/"},{"@type":"ListItem","position":2,"name":"ASCERTAIN at the 6th EUROPEAN CAR T-CELL MEETING in Valencia"}]},{"@type":"WebSite","@id":"https:\/\/www.access2meds.eu\/#website","url":"https:\/\/www.access2meds.eu\/","name":"ASCERTAIN","description":"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES","publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.access2meds.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hr"},{"@type":"Organization","@id":"https:\/\/www.access2meds.eu\/#organization","name":"ASCERTAIN","url":"https:\/\/www.access2meds.eu\/","logo":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","width":1,"height":1,"caption":"ASCERTAIN"},"image":{"@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ASCERTAIN_EU","https:\/\/www.linkedin.com\/company\/ascertain-eu\/","https:\/\/www.youtube.com\/@ascertainproject"]},{"@type":"Person","@id":"https:\/\/www.access2meds.eu\/#\/schema\/person\/84cb4791d2eba62e68ecb7f29dba9391","name":"Lena Jessen"}]}},"_links":{"self":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts\/1709","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/comments?post=1709"}],"version-history":[{"count":3,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts\/1709\/revisions"}],"predecessor-version":[{"id":1847,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts\/1709\/revisions\/1847"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/media\/1450"}],"wp:attachment":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/media?parent=1709"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/categories?post=1709"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/tags?post=1709"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}